Detalhe da pesquisa
1.
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis.
Lancet Oncol
; 25(4): 455-462, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458207
2.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Lancet Oncol
; 24(2): e86-e95, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725153
3.
The Development of the Oncology Center of Excellence Patient-Friendly Language Glossary of Oncology Clinical Trial Terms.
Oncologist
; 28(5): 379-382, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882084
4.
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Qual Life Res
; 32(8): 2281-2292, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935467
5.
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.
Lancet Oncol
; 23(5): e229-e234, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489354
6.
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
Cancer
; 128(4): 808-818, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634139
7.
US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast Cancer.
Value Health
; 25(4): 566-570, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365300
8.
Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events.
Clin Trials
; 19(3): 267-273, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575012
9.
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Lancet Oncol
; 22(9): 1230-1239, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310904
10.
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Oncologist
; 26(10): e1786-e1799, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196068
11.
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Oncologist
; 26(5): 433-438, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687763
12.
Does Knowledge of Treatment Assignment Affect Patient Report of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials.
Value Health
; 24(6): 822-829, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119080
13.
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types.
Value Health
; 24(9): 1302-1307, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452710
14.
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
Lancet Oncol
; 21(10): e488-e494, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002444
15.
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Lancet Oncol
; 21(2): e97-e103, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007210
16.
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 21(2): 250-260, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859246
17.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007209
18.
Public-private partnerships in transplant drug development.
Am J Transplant
; 20(2): 377-381, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553120
19.
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs.
Oncologist
; 25(4): 348-354, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297444
20.
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.
J Urol
; 203(1): 115-119, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502940